Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care With COVID-19: Randomised Controlled Trial
Stopped Steering Committee decision in accordance with stopping rule 1: Emergence of new data
Conditions
- COVID-19
- Respiratory Failure
Interventions
- DRUG: Azithromycin
- DRUG: Hydroxychloroquine
- DRUG: Placebo
Sponsor
Frantisek Duska, MD, PhD
Collaborators
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]